Natus Medical Incorporated announced that on February 22, 2022, D. Christopher Chung, M.D., Vice President of Quality, Regulatory Affairs and Chief Medical Officer, notified the Company of his decision to retire from the Company on April 1, 2022. Thereafter, Dr. Chung will provide consulting services to the Company on a part-time basis.
Natus Medical Incorporated
Equities
NTUS
US6390501038
Advanced Medical Equipment & Technology
1st Jan change | Capi. | |
---|---|---|
+10.03% | 223B | |
+13.59% | 195B | |
+20.01% | 144B | |
+30.83% | 111B | |
+2.05% | 65.01B | |
+15.38% | 53.02B | |
+3.96% | 50.45B | |
+8.37% | 44.15B | |
+3.27% | 36.45B |